Biotech Investors Allege $27M Pump-And-Dump Scheme
Shareholders of BioZone Pharmaceuticals Inc.'s successor slammed its former executives and high-profile investors with a lawsuit Thursday alleging they ensnared the company in a $27 million pump-and-dump scheme that drove down...To view the full article, register now.
Already a subscriber? Click here to view full article